Hologic Stock Performance
| HOLX Stock | USD 68.12 0.95 1.41% |
Hologic has a performance score of 8 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.38, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Hologic will likely underperform. Hologic right now retains a risk of 1.17%. Please check out Hologic maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Hologic will be following its current trending patterns.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Hologic are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady essential indicators, Hologic may actually be approaching a critical reversion point that can send shares even higher in September 2025. ...more
Actual Historical Performance (%)
One Day Return (2.31) | Five Day Return (1.65) | Year To Date Return (6.37) | Ten Year Return 76.62 | All Time Return 2.7 K |
Last Split Factor 2:1 | Last Split Date 2008-04-03 |
1 | Global Dermal Fillers Market is Predicted to Reach USD 12 Billion by 2032 DelveInsight | 07/31/2025 |
2 | IQ EQ FUND MANAGEMENT IRELAND Ltd Sells 248 Shares of Hologic, Inc. | 08/04/2025 |
3 | Hologics Diagnostics Arm Set for Long-Term Upside Whats Behind It | 08/08/2025 |
4 | Latest Global Digital Mammography Market SizeShare Worth USD 5.32 Billion by 2034 at a 11.26 percent CAGR Custom Market Insights | 08/11/2025 |
5 | STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMer... | 08/12/2025 |
6 | Hologics Q2 Earnings Call Our Top 5 Analyst Questions | 08/13/2025 |
7 | What Are Wall Street Analysts Target Price for Hologic Stock | 08/14/2025 |
8 | Townsquare Capital LLC Has 418,000 Stock Holdings in Hologic, Inc. HOLX | 08/18/2025 |
9 | WASHINGTON RADIOLOGYS K STREET MULTIMODALITY IMAGING CENTER MOVES INTO NEW STATE-OF-THE-ART FACILITY | 08/19/2025 |
10 | Latest Global Biologics and Biosimilars Market SizeShare Worth USD 1,320.19 Billion by 2034 at a 10.42 percent CAGR Custom Market Insights | 08/21/2025 |
| Begin Period Cash Flow | 2.8 B | |
| Total Cashflows From Investing Activities | -781 M |
Hologic Relative Risk vs. Return Landscape
If you would invest 6,217 in Hologic on May 24, 2025 and sell it today you would earn a total of 500.00 from holding Hologic or generate 8.04% return on investment over 90 days. Hologic is currently generating 0.1336% in daily expected returns and assumes 1.1724% risk (volatility on return distribution) over the 90 days horizon. In different words, 10% of stocks are less volatile than Hologic, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hologic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hologic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hologic, and traders can use it to determine the average amount a Hologic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.114
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | HOLX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.17 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Hologic is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hologic by adding it to a well-diversified portfolio.
Hologic Fundamentals Growth
Hologic Stock prices reflect investors' perceptions of the future prospects and financial health of Hologic, and Hologic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hologic Stock performance.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0669 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 15.94 B | ||||
| Shares Outstanding | 222.42 M | ||||
| Price To Earning | 10.21 X | ||||
| Price To Book | 3.16 X | ||||
| Price To Sales | 3.70 X | ||||
| Revenue | 4.03 B | ||||
| Gross Profit | 2.46 B | ||||
| EBITDA | 1.3 B | ||||
| Net Income | 789.5 M | ||||
| Cash And Equivalents | 2.39 B | ||||
| Cash Per Share | 9.59 X | ||||
| Total Debt | 2.66 B | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 3.90 X | ||||
| Book Value Per Share | 21.79 X | ||||
| Cash Flow From Operations | 1.29 B | ||||
| Earnings Per Share | 2.41 X | ||||
| Market Capitalization | 14.94 B | ||||
| Total Asset | 9.16 B | ||||
| Retained Earnings | 2.85 B | ||||
| Working Capital | 2.79 B | ||||
| Current Asset | 137.94 M | ||||
| Current Liabilities | 39.47 M | ||||
About Hologic Performance
Evaluating Hologic's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Hologic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hologic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 115.08 | 118.62 | |
| Return On Tangible Assets | 0.09 | 0.10 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.09 | 0.10 |
Things to note about Hologic performance evaluation
Checking the ongoing alerts about Hologic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Latest Global Biologics and Biosimilars Market SizeShare Worth USD 1,320.19 Billion by 2034 at a 10.42 percent CAGR Custom Market Insights |
- Analyzing Hologic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hologic's stock is overvalued or undervalued compared to its peers.
- Examining Hologic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hologic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hologic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hologic's stock. These opinions can provide insight into Hologic's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.